Cargando…

Mesenchymal stem cell therapy targeting mitochondrial dysfunction in acute kidney injury

Mitochondria take part in a network of cellular processes that regulate cell homeostasis. Defects in mitochondrial function are key pathophysiological changes during acute kidney injury (AKI). Mesenchymal stem cells (MSCs) have shown promising regenerative effects in experimental AKI models, but the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Lingfei, Hu, Chenxia, Zhang, Ping, Jiang, Hua, Chen, Jianghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498508/ https://www.ncbi.nlm.nih.gov/pubmed/31046805 http://dx.doi.org/10.1186/s12967-019-1893-4

Ejemplares similares

Novel preconditioning strategies for enhancing the migratory ability of mesenchymal stem cells in acute kidney injury
por: Zhao, Lingfei, et al.
Publicado: (2018)

Preconditioning strategies for improving the survival rate and paracrine ability of mesenchymal stem cells in acute kidney injury
por: Zhao, Lingfei, et al.
Publicado: (2018)

Melatonin preconditioning is an effective strategy for mesenchymal stem cell‐based therapy for kidney disease
por: Zhao, Lingfei, et al.
Publicado: (2019)

Genetic communication by extracellular vesicles is an important mechanism underlying stem cell-based therapy-mediated protection against acute kidney injury
por: Zhao, Lingfei, et al.
Publicado: (2019)

Cellular senescence, a novel therapeutic target for mesenchymal stem cells in acute kidney injury
por: Zhao, Lingfei, et al.
Publicado: (2020)

Regenerative abilities of mesenchymal stem cells via acting as an ideal vehicle for subcellular component delivery in acute kidney injury
por: Zhao, Lingfei, et al.
Publicado: (2020)

Preconditioning is an effective strategy for improving the efficiency of mesenchymal stem cells in kidney transplantation
por: Zhao, Lingfei, et al.
Publicado: (2020)

Induction therapy with mesenchymal stromal cells in kidney transplantation: a meta-analysis
por: Zhao, Lingfei, et al.
Publicado: (2021)

Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models
por: Zhao, Lingfei, et al.
Publicado: (2019)

Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases
por: Hu, Chenxia, et al.
Publicado: (2019)

Regulation of the mitochondrial reactive oxygen species: Strategies to control mesenchymal stem cell fates ex vivo and in vivo
por: Hu, Chenxia, et al.
Publicado: (2018)

Modulating autophagy in mesenchymal stem cells effectively protects against hypoxia- or ischemia-induced injury
por: Hu, Chenxia, et al.
Publicado: (2019)

Transplantation of mesenchymal stem cells and their derivatives effectively promotes liver regeneration to attenuate acetaminophen-induced liver injury
por: Hu, Chenxia, et al.
Publicado: (2020)

Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury
por: Hu, Chenxia, et al.
Publicado: (2020)

Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis
por: Hu, Chenxia, et al.
Publicado: (2019)

Haemoglobin variability and all‐cause mortality in haemodialysis patients: A systematic review and meta‐analysis
por: Zhao, Lingfei, et al.
Publicado: (2019)

Combination of mesenchymal stromal cells and machine perfusion is a novel strategy for organ preservation in solid organ transplantation
por: Zhao, Lingfei, et al.
Publicado: (2021)

TRPM2 protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction via modulating autophagy
por: Yu, Binfeng, et al.
Publicado: (2023)

Molecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury
por: Lee, Pei-Wen, et al.
Publicado: (2021)

Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury
por: Fu, Zhangning, et al.
Publicado: (2023)

NOX4 is a potential therapeutic target in septic acute kidney injury by inhibiting mitochondrial dysfunction and inflammation
por: Li, Jiameng, et al.
Publicado: (2023)

Autophagy regulation is an effective strategy to improve the prognosis of chemically induced acute liver injury based on experimental studies
por: Hu, Chenxia, et al.
Publicado: (2020)

Role of Transcription Factor EB in Mitochondrial Dysfunction of Cisplatin-Induced Acute Kidney Injury
por: Wang, Shujun, et al.
Publicado: (2023)

0889. Mitochondrial dysfunction contributes to sepsis-induces acute kidney injury
por: Greco, E, et al.
Publicado: (2014)

Urinary Mitochondrial DNA Identifies Renal Dysfunction and Mitochondrial Damage in Sepsis-Induced Acute Kidney Injury
por: Hu, Qiongyuan, et al.
Publicado: (2018)

Preconditioning influences mesenchymal stem cell properties in vitro and in vivo
por: Hu, Chenxia, et al.
Publicado: (2018)

Urinary mitochondrial DNA is a biomarker of mitochondrial disruption and renal dysfunction in acute kidney injury
por: Whitaker, Ryan M., et al.
Publicado: (2015)

Pre‐conditions for eliminating mitochondrial dysfunction and maintaining liver function after hepatic ischaemia reperfusion
por: Hu, Chenxia, et al.
Publicado: (2017)

Melatonin and its protective role in attenuating warm or cold hepatic ischaemia/reperfusion injury
por: Hu, Chenxia, et al.
Publicado: (2021)

Regulation of autophagy protects against liver injury in liver surgery‐induced ischaemia/reperfusion
por: Hu, Chenxia, et al.
Publicado: (2021)

Sirtuin 3 deficiency promotes acute kidney injury induced by sepsis via mitochondrial dysfunction and apoptosis
por: Fan, Heng, et al.
Publicado: (2021)

Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation
por: Angelova, Plamena R., et al.
Publicado: (2017)

The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy
por: Huang, Haoyan, et al.
Publicado: (2023)

Targeting Murine Mesenchymal Stem Cells to Kidney Injury Molecule‐1 Improves Their Therapeutic Efficacy in Chronic Ischemic Kidney Injury
por: Zou, Xiangyu, et al.
Publicado: (2018)

Differentially expressed miRNAs in sepsis-induced acute kidney injury target oxidative stress and mitochondrial dysfunction pathways
por: Ge, Qin-Min, et al.
Publicado: (2017)

Tubular β-catenin alleviates mitochondrial dysfunction and cell death in acute kidney injury
por: Li, Hongyu, et al.
Publicado: (2022)

Melatonin plays critical role in mesenchymal stem cell-based regenerative medicine in vitro and in vivo
por: Hu, Chenxia, et al.
Publicado: (2019)

The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation
por: Hu, Chenxia, et al.
Publicado: (2019)

Immunomodulatory Effects of Mesenchymal Stem Cells on Drug-Induced Acute Kidney Injury
por: Han, Qiuxia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ta2flfoviuf0jh4ttf523668qi